Dr. Lawrence Corey

For the Media

Dr. Lawrence Corey

Dr. Larry Corey is president and director emeritus of Fred Hutch he helped drive lifesaving discoveries across an even broader spectrum of diseases. As a member of Hutch's Vaccine and Infectious Disease Division, Dr. Corey has led some of the most significant advances in medicine in the last 30 years, including the development of safe and effective antivirals for herpes viruses, HIV and hepatitis infections. Dr. Corey is co-prinicipal investigator of the HIV Vaccine Trials Network.

Resources for more information

  • Overview of Larry Corey's Research
    The development of safe and effective antivirals for herpes viruses, HIV and hepatitis infections. 
  • Larry Corey – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Larry Corey - Featured Researcher Profile
    An international expert in virology, immunology and vaccine development, Corey made a major discovery in the early 1980s when he demonstrated the effectiveness of the world’s first antiviral therapy (acyclovir) for the treatment of herpes simplex virus-2 (genital herpes). 
  • The Corey Lab
    The Corey Lab investigates the underlying mechanisms between herpes simplex virus pathogenesis and the host immune response. Specifically, the associations between HSV-2 disease severity and the quantity, quality and diversity of tissue resident memory CD8+ T cells persisting after HSV-2 reactivation in humans.
  • Vaccine and Infectious Disease Division
    VIDD’s research aims at preventing, diagnosing, treating and understanding infectious diseases. There is a wide range of research topics under investigation across the fields of biology, medicine and public health. VIDD is organized into four research programs that integrate multiple research interests.
  • HIV Vaccine Trials Network (HVTN)
    The HIV Vaccine Trials Network (HVTN) is the world’s largest publicly funded multi-disciplinary international collaboration facilitating the development of vaccines to prevent HIV/AIDS. The HVTN conducts all phases of clinical trials, from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of Larry Corey.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.